Impact ledger
Gossamer Bio, Inc. (GOSS)
7 events mapped to this ticker since 2026-06-17.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-07-01 | interest_expense | Bullish | — | 0.70 |
| 2026-07-01 | dilution | Bullish | — | 0.70 |
| 2026-06-17 | share_count | Bullish | — | 0.70 |
| 2026-06-17 | net_debt | Bullish | — | 0.70 |
| 2026-06-17 | revenue | Bullish | — | 0.70 |
| 2026-06-17 | net_debt | Bearish | — | 0.70 |
| 2026-06-17 | interest_expense | Bearish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-02 | Event | Dilution risk from convertible notes becoming more apparent, potentially increasing share count and putting downward pressure on stock price. | Bearish | 1-3m | 0.70 |
| 2026-07-01 | Event | Regulatory filing indicating a material definitive agreement. The specific nature of the agreement is unknown, but it could relate to financing, a partnership, or an acquisition, all of which are significant for a biotech company. | watch | 1-5d | 0.80 |
| 2026-07-01 | Event | Dilution risk from convertible notes; very low conversion price suggests significant potential for new shares to be issued, increasing share count. | Bearish | 1-3m | 0.80 |
| 2026-06-17 | Event | Direct impact from M&A announcement. The specific terms of the agreement (e.g., acquisition price, structure) will dictate the immediate stock price reaction. | watch | 1-5d | 0.80 |
| 2026-06-17 | Event | Debt restructuring and equity dilution. The exchange offer successfully converted a significant portion of existing convertible notes into new, higher-interest secured notes and equity. This reduces near-term debt maturities but increases future interest expense and dilutes existing shareholders. | mixed | 1-3m | 0.70 |
| 2026-06-17 | Event | Debt restructuring, dilution, and interest expense changes | mixed | 1-3m | 0.70 |
| 2026-06-17 | Event | Regulation FD disclosure often precedes or accompanies significant company news (e.g., clinical trial results, financing, strategic updates). The market will be watching for the content of this disclosure. | watch | 1-5d | 0.60 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for GOSS, start a trial or view the GOSS entity page.